Fracture Prevention with Infrequent Zoledronate in Women 50 to 60 Years of Age

Zoledronate administered every 12 to 18 months prevents fractures in older women. Ten years after initiation of this trial, zoledronate administered at baseline and 5 years prevented vertebral fracture.

​   The New England Journal of Medicine: Search Results in Endocrinology